NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,284,279 | -34.3% | 74,221 | -27.7% | 0.00% | -50.0% |
| Q2 2023 | $4,997,679 | -13.4% | 102,690 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $5,770,484 | +377549.5% | 103,971 | +173.3% | 0.00% | – |
| Q4 2022 | $1,528 | -99.9% | 38,049 | +4.9% | 0.00% | -100.0% |
| Q3 2022 | $1,589,000 | +16.4% | 36,259 | -5.7% | 0.00% | – |
| Q2 2022 | $1,365,000 | -75.0% | 38,468 | -71.4% | 0.00% | -100.0% |
| Q1 2022 | $5,466,000 | -53.7% | 134,342 | +6.2% | 0.00% | -50.0% |
| Q4 2021 | $11,814,000 | -6.7% | 126,507 | +11.3% | 0.00% | 0.0% |
| Q3 2021 | $12,659,000 | +15.2% | 113,641 | +17.5% | 0.00% | +33.3% |
| Q2 2021 | $10,985,000 | +33.0% | 96,731 | +18.9% | 0.00% | 0.0% |
| Q1 2021 | $8,260,000 | +61.6% | 81,348 | +58.4% | 0.00% | +50.0% |
| Q4 2020 | $5,111,000 | +627.0% | 51,356 | +428.0% | 0.00% | – |
| Q3 2020 | $703,000 | – | 9,727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |